References
- Sankar MJ, Agarwal R, Deorari AK, et al. Sepsis in the newborn. Indian J Pediatr. 2008;75:261–266.
- Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–1780.
- Wattal C, Kler N, Oberoi JK, et al. Neonatal sepsis: mortality and morbidity in neonatal sepsis due to multidrug-resistant (MDR) organisms: part 1. Indian J Pediatr. 2020;87:117–121.
- Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J Pediatr 2020;96(1):80–86.
- Tzialla C, Manzoni P, Achille C, et al. New diagnostic possibilities for neonatal sepsis. Am J Perinatol. 2018;35:575–577.
- Deshmukh M, Mehta S, Patole S. Sepsis calculator for neonatal early onset sepsis – a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021;34:1832–1840.
- Ruan L, Chen GY, Liu Z, et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care. 2018;22(1):316.
- Bellos I, Fitrou G, Pergialiotis V, et al. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J Pediatr. 2018;177(2021):625–632.
- Milas GP, Issaris V. Proadrenomedullin and neonatal sepsis: a systematic review and meta-analysis of diagnostic accuracy. Eur J Pediatr. 2021;181(1):59–71.
- Haapasalo K, Meri S. Regulation of the complement system by pentraxins. Front Immunol. 2019;10:1750.
- Lee YT, Gong M, Chau A, et al. Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis. J Infect. 2018;76(1):1–10.
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:2021.
- Wells GA, Shea B, O’Connell D, et al. Ottawa Hospital Research Institute [Internet]. [cited 2021 Sep 20]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- The Nordic Cochrane Centre. The cochrane collaboration. Review manager 5.3. Copenhagen; 2020.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
- Schwarzer G. Package “meta” title general package for meta-analysis; 2021 [cited 2021 Jun 9]. Available from: https://www.springer.com/gp/book/9783319214153.
- Cochrane Collaboration. 9.6.4 Meta-regression [Internet]. [cited 2021 Jun 13]. Available from: https://handbook-5-1.cochrane.org/chapter_9/9_6_4_meta_regression.htm.
- Schwarzer G, Carpenter J, Rücker G. Empirical evaluation suggests copas selection model preferable to trim-and-fill method for selection bias in meta-analysis. J Clin Epidemiol. 2010;63:282–288.
- Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406.
- Fahmey SS, Mostafa N. Pentraxin 3 as a novel diagnostic marker in neonatal sepsis. J Neonatal Perinatal Med. 2019;12:437–442.
- Tunç T, Polat A, Özdemir R, et al. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis. J Neonatal Perinatal Med.. 2020;13:39–45.
- Sabry A, Ibrahim M, Khashana A. Assessment of pentraxin 3 in a systemic inflammatory response occurring with neonatal bacterial infection. J Neonatal Perinatal Med. 2021;14(4):563–568.
- Battal F, Bulut ÖE, Yıldırım Ş, et al. Serum pentraxin 3 concentration in neonatal sepsis. J Pediatr Infect Dis. 2019;14:219–222.
- Baumert M, Surmiak P, Szymkowiak M, et al. The assessment of pentraxin 3: a novel biomarker in early detection of infection in newborns. Biomed Res Int. 2021;2021:6638622.
- Hu C, Zhou Y, Liu C, et al. Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock. Oncotarget. 2017;9:5125–5136.
- Ketter P, Yu JJ, Cap AP, et al. Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis. 2016;12:501–507.
- Hamed S, Behnes M, Pauly D, et al. Diagnostic value of pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions. BMC Infect Dis. 2017;17(1):554.
- Lannergård A, Rosenström F, Normann E, et al. Serum pentraxin 3 concentrations in neonates. Ups J Med Sci. 2014;119(1):62–64.